Bajaj Healthcare [BAJAJHCARE] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Bajaj Healthcare

NSE

Aarti Drugs

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bajaj Healthcare wins in 7 metrics, Aarti Drugs wins in 13 metrics, with 0 ties. Aarti Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Bajaj Healthcare	Aarti Drugs	Better
P/E Ratio (TTM)	29.44	23.75	Aarti Drugs
Price-to-Book Ratio	3.01	3.28	Bajaj Healthcare
Debt-to-Equity Ratio	47.89	44.92	Aarti Drugs
PEG Ratio	0.66	0.37	Aarti Drugs
EV/EBITDA	19.65	17.15	Aarti Drugs
Profit Margin (TTM)	7.90%	7.80%	Bajaj Healthcare
Operating Margin (TTM)	12.68%	10.11%	Bajaj Healthcare
EBITDA Margin (TTM)	12.68%	10.11%	Bajaj Healthcare
Return on Equity	8.47%	12.28%	Aarti Drugs
Return on Assets (TTM)	4.74%	6.53%	Aarti Drugs
Free Cash Flow (TTM)	$100.82M	$674.20M	Aarti Drugs
Dividend Yield	0.19%	0.22%	Aarti Drugs
1-Year Return	9.57%	-12.97%	Bajaj Healthcare
Price-to-Sales Ratio (TTM)	2.53	1.85	Aarti Drugs
Enterprise Value	$16.25B	$50.72B	Aarti Drugs
EV/Revenue Ratio	2.91	2.09	Aarti Drugs
Gross Profit Margin (TTM)	45.85%	36.77%	Bajaj Healthcare
Revenue per Share (TTM)	$182	$265	Aarti Drugs
Earnings per Share (Diluted)	$15.10	$20.66	Aarti Drugs
Beta (Stock Volatility)	0.07	0.21	Bajaj Healthcare

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Bajaj Healthcare vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Bajaj Healthcare	-0.55%	-2.96%	-13.50%	-21.01%	-34.80%	-28.93%
Aarti Drugs	-2.51%	0.27%	-9.96%	2.11%	28.03%	7.74%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Bajaj Healthcare	9.57%	22.74%	23.58%	23.58%	23.58%	23.58%
Aarti Drugs	-12.97%	12.03%	-33.03%	242.63%	2,725.27%	2,466.68%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Bajaj Healthcare (BAJAJHCARE): View Full Stock Overview

Aarti Drugs (AARTIDRUGS): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Bajaj Healthcare vs Aarti Drugs

Metric	BAJAJHCARE	AARTIDRUGS
Market Information
Market Cap i	₹14.16B	₹44.80B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	89,345	150,557
90 Day Avg. Volume i	205,862	593,779
Last Close	₹446.90	₹478.45
52 Week Range	₹333.80 - ₹745.00	₹312.00 - ₹635.00
% from 52W High	-40.01%	-24.65%
All-Time High	₹745.00 (Mar 17, 2025)	₹1,026.95 (Oct 05, 2020)
% from All-Time High	-40.01%	-53.41%
Growth Metrics
Quarterly Revenue Growth	0.13%	0.06%
Quarterly Earnings Growth	0.66%	0.62%
Financial Health
Profit Margin (TTM) i	0.08%	0.08%
Operating Margin (TTM) i	0.13%	0.10%
Return on Equity (TTM) i	0.08%	0.12%
Debt to Equity (MRQ) i	47.89	44.92
Cash & Liquidity
Book Value per Share (MRQ)	₹147.63	₹149.84
Cash per Share (MRQ)	₹1.41	₹2.48
Operating Cash Flow (TTM) i	₹13.95M	₹2.83B
Levered Free Cash Flow (TTM) i	₹394.96M	₹1.68B
Dividends
Last 12-Month Dividend Yield i	0.19%	0.22%
Last 12-Month Dividend i	₹1.00	₹1.00

Valuation & Enterprise Metrics Analysis: Bajaj Healthcare vs Aarti Drugs

Metric	BAJAJHCARE	AARTIDRUGS
Price Ratios
P/E Ratio (TTM) i	29.44	23.75
Forward P/E i	N/A	14.98
PEG Ratio i	0.66	0.37
Price to Sales (TTM) i	2.53	1.85
Price to Book (MRQ) i	3.01	3.28
Market Capitalization
Market Capitalization i	₹14.16B	₹44.80B
Enterprise Value i	₹16.25B	₹50.72B
Enterprise Value Metrics
Enterprise to Revenue i	2.91	2.09
Enterprise to EBITDA i	19.65	17.15
Risk & Other Metrics
Beta i	0.07	0.21
Book Value per Share (MRQ) i	₹147.63	₹149.84

Financial Statements Comparison: Bajaj Healthcare vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	BAJAJHCARE	AARTIDRUGS
Revenue/Sales i	₹1.54B	₹6.77B
Cost of Goods Sold i	₹939.69M	₹4.37B
Gross Profit i	₹605.04M	₹2.40B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹42.26M	₹784.50M
EBITDA i	₹253.29M	₹951.90M
Pre-Tax Income i	₹117.22M	₹711.50M
Income Tax i	₹1.29M	₹83.80M
Net Income (Profit) i	₹111.78M	₹627.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	BAJAJHCARE	AARTIDRUGS
Cash & Equivalents i	₹26.04M	₹45.80M
Total Current Assets i	₹5.61B	₹13.38B
Total Current Liabilities i	₹2.97B	₹8.37B
Long-Term Debt i	₹649.19M	₹2.86B
Total Shareholders Equity i	₹4.66B	₹13.69B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	₹2.37B	₹8.59B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	BAJAJHCARE	AARTIDRUGS
Operating Cash Flow i	₹7.46M	N/A
Capital Expenditures i	₹-66.96M	N/A
Free Cash Flow i	₹5.04M	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	₹0	N/A

Short Interest & Institutional Ownership Analysis

Metric	BAJAJHCARE	AARTIDRUGS
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	89,345	150,557
Average Daily Volume (90 Day) i	205,862	593,779
Shares Outstanding i	31.58M	91.27M
Float Shares i	9.89M	35.46M
% Held by Insiders i	0.64%	0.61%
% Held by Institutions i	0.02%	0.11%

Dividend Analysis & Yield Comparison: Bajaj Healthcare vs Aarti Drugs

Metric	BAJAJHCARE	AARTIDRUGS
Last 12-Month Dividend i	₹1.00	₹1.00
Last 12-Month Dividend Yield i	0.19%	0.22%
3-Year Avg Annual Dividend i	₹1.17	₹1.00
3-Year Avg Dividend Yield i	0.29%	0.23%
3-Year Total Dividends i	₹3.50	₹3.00
Ex-Dividend Date	Sep 23, 2024	Feb 04, 2025

Bajaj Healthcare [BAJAJHCARE] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison